Furthermore, we showed that miR128-1 targeted BMI1 and E2F3, and miR128-1 overexpression down-regulated BMI1 and E2F3 in glioblastoma cells both in vitro and in mouse tumor xenografts. Here, E2F3 is linked to neoplasm.